288 related articles for article (PubMed ID: 15680267)
21. Endothelial mechanisms underlying responses to acetylcholine in the horse deep dorsal penile vein.
Martínez AC; Prieto D; Hernández M; Rivera L; Recio P; García-Sacristán A; Benedito S
Eur J Pharmacol; 2005 May; 515(1-3):150-9. PubMed ID: 15894308
[TBL] [Abstract][Full Text] [Related]
22. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
23. Exploring vascular benefits of endothelium-derived nitric oxide.
Cockcroft JR
Am J Hypertens; 2005 Dec; 18(12 Pt 2):177S-183S. PubMed ID: 16373196
[TBL] [Abstract][Full Text] [Related]
24. Two "knockout" mouse models demonstrate that aortic vasodilatation is mediated via alpha2a-adrenoceptors located on the endothelium.
Shafaroudi MM; McBride M; Deighan C; Wokoma A; Macmillan J; Daly CJ; McGrath JC
J Pharmacol Exp Ther; 2005 Aug; 314(2):804-10. PubMed ID: 15878998
[TBL] [Abstract][Full Text] [Related]
25. Urocortin-induced relaxation in the human internal mammary artery.
Chen ZW; Huang Y; Yang Q; Li X; Wei W; He GW
Cardiovasc Res; 2005 Mar; 65(4):913-20. PubMed ID: 15721872
[TBL] [Abstract][Full Text] [Related]
26. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
[TBL] [Abstract][Full Text] [Related]
27. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
[TBL] [Abstract][Full Text] [Related]
28. alpha2-Adrenoceptor subsensitivity in mesenteric vascular bed of cholestatic rats: the role of nitric oxide and endogenous opioids.
Borhani AA; Houshmand G; Samini M; Namiranian K; Hajrasouliha AR; Tavakoli S; Ebrahimi F; Dehpour AR
Eur J Pharmacol; 2005 May; 514(2-3):183-9. PubMed ID: 15910805
[TBL] [Abstract][Full Text] [Related]
29. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
30. [Endothelioprotective properties of L-arginine in a nitric oxide deficiency model].
Pokrovskiĭ MV; Pokrovskaia TG; Kochkarov VI; Artiushkova EB
Eksp Klin Farmakol; 2008; 71(2):29-31. PubMed ID: 18488903
[TBL] [Abstract][Full Text] [Related]
31. Vasodilator effects of leptin on canine isolated mesenteric arteries and veins.
Mohammed MM; Myers DS; Sofola OA; Hainsworth R; Drinkhill MJ
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):771-4. PubMed ID: 17600555
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms involved in the vasodilator effect induced by diosgenin in rat superior mesenteric artery.
Dias KL; Correia Nde A; Pereira KK; Barbosa-Filho JM; Cavalcante KV; Araújo IG; Silva DF; Guedes DN; Neto Mdos A; Bendhack LM; Medeiros IA
Eur J Pharmacol; 2007 Nov; 574(2-3):172-8. PubMed ID: 17689524
[TBL] [Abstract][Full Text] [Related]
35. Prolonged effect of a novel S-nitrosated glyco-amino acid in endothelium-denuded rat femoral arteries: potential as a slow release nitric oxide donor drug.
Megson IL; Greig IR; Gray GA; Webb DJ; Butler AR
Br J Pharmacol; 1997 Dec; 122(8):1617-24. PubMed ID: 9422806
[TBL] [Abstract][Full Text] [Related]
36. Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol.
Ignarro LJ
Cardiovasc Ther; 2008; 26(2):115-34. PubMed ID: 18485134
[TBL] [Abstract][Full Text] [Related]
37. The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca2+]i.
Cseplo P; Vamos Z; Ivic I; Torok O; Toth A; Koller A
PLoS One; 2016; 11(10):e0164010. PubMed ID: 27716772
[TBL] [Abstract][Full Text] [Related]
38. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
39. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
Brodde OE; Philipp T
Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
